Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial

Y. Gao, B. Weenink, M. J. van den Bent, L. Erdem-Eraslan, J. M. Kros, P. A. E. Sillevis Smitt, K. Hoang-Xuan, A. A. Brandes, M. Vos, F. Dhermain, R. Enting, G. F. Ryan, O. Chinot, M. Ben Hassel, M. E. van Linde, W. P. Mason, J. M. M. Gijtenbeek, C. Balana, A. von Deimling, Th GorliaR. Stupp, M. E. Hegi, B. G. Baumert, P. J. French

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)168-178
Number of pages11
JournalEuropean Journal of Cancer
Volume94
DOIs
Publication statusPublished - 1 May 2018

Keywords

  • Low grade glioma
  • Intrinsic subtype
  • Pilocytic astrocytoma
  • Gene expression profiling
  • Immunophenotype
  • BELOB
  • OLIGODENDROGLIAL BRAIN-TUMORS
  • CENTRAL-NERVOUS-SYSTEM
  • PHASE-III TRIAL
  • RANDOMIZED-TRIAL
  • VINCRISTINE CHEMOTHERAPY
  • PILOCYTIC ASTROCYTOMAS
  • ADJUVANT PROCARBAZINE
  • RADIATION-THERAPY
  • EORTC 22033-26033
  • MGMT METHYLATION

Cite this

Gao, Y., Weenink, B., van den Bent, M. J., Erdem-Eraslan, L., Kros, J. M., Smitt, P. A. E. S., Hoang-Xuan, K., Brandes, A. A., Vos, M., Dhermain, F., Enting, R., Ryan, G. F., Chinot, O., Ben Hassel, M., van Linde, M. E., Mason, W. P., Gijtenbeek, J. M. M., Balana, C., von Deimling, A., ... French, P. J. (2018). Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial. European Journal of Cancer, 94, 168-178. https://doi.org/10.1016/j.ejca.2018.02.023